We have located links that may give you full text access.
[Who pays the "dangerous liaisons" between doctors and industry?]
Recenti Progressi in Medicina 2016 September
The problem regarding the influence that industry may exert on physicians through various types of payments is not of exclusively ethical nature, but has also important practical implications. Using money, industry may distort prescribing habits in favor of their own products, generally more costly, but not always more effective or better tolerated. Moreover, industry is interested in increasing the number of people to whom their products could be prescribed, thus widening the market. If physicians do not oppose these enticements, the patients and the citizens' tax funded National Health Service will pay the bill. In fact, any largesse from the Sales & Marketing divisions of pharmaceutical industries is paid, indirectly and via major financial returns related to an increase in prescriptions, by citizens. In USA this is now demonstrated with the analysis of the first data on transfers of money from industry to physicians made publicly available after the implementation of the Physician Payment Sunshine Act.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app